Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Tang ST, Zhang Q, Tang HQ, et al
With 24/7 access to doctors across all 50 states, Doctronic provides expert guidance tailored to your health needs
dpp-4_inhibitors DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)
It is becoming increasingly popular in sports rehabilitation, peptide therapy, biohacking, musculoskeletal recovery, and gastrointestinal health communities
US$ 25.76
US$ 20.73
US$ 21.44
US$ 26.49
US$ 28.56
US$ 23.78
US$ 29.41
